Aman Mahajan
Principal investigator, leads SENSYDIA CORPORATION.
MedtechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2023First federal award
$3.0MFederal grants as PI3 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
3 awards · $3.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 13, 2026 | NIH | STTR Phase II A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension | $816K | SENSYDIA CORPORATION |
| Apr 16, 2025 | NIH | STTR Phase II A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension | $1.6M | SENSYDIA CORPORATION |
| May 5, 2023 | NIH | STTR Phase I A non-invasive, automated platform for hemodynamic assessment of patients at risk of heart failure or pulmonary hypertension | $606K | SENSYDIA CORPORATION with UNIVERSITY OF PITTSBURGH HEALTH SYSTEM |
Peer ranks
Federal funding#645
Awards as PI#927
Patents#505
Companies
- SENSYDIA CORPORATIONLeads (SEC Form D) · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.